Immunome, Inc. (IMNM) vs Vericel Corporation (VCEL)

• Immunome, Inc. IMNM 18.65 ▲ +4.13%
• Vericel Corporation VCEL 54.47 ▲ +5.20%

Immunome, Inc. and Vericel Corporation are both Biotechnology companies. Vericel Corporation is the larger, with a market value of $2.7B against $2.1B — 1.3× the size. Immunome, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.9×. Vericel Corporation grew revenue faster over the last twelve months: 25.3% against 16.7%. Vericel Corporation has the higher net margin (10.3% vs 0.00%) and the higher return on invested capital (7.88% vs −3,323.0%). Across the 17 metrics below, Vericel Corporation leads on 14 and Immunome, Inc. on 3.